1. The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of
    ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
    Tokunaga H, Mikami M, Nagase S, Kobayashi Y, Tabata T, Kaneuchi M, Satoh T, Hirashima Y, Matsumura N, Yokoyama Y, Kawana K, Kyo S, Aoki D, Katabuchi H.
    J Gynecol Oncol. 2021 Mar;32(2):e49. doi: 10.3802/jgo.2021.32.e49.
  2. Whole-exome sequencing of rare site endometriosis-associated cancer
    Kurose S, Nakayama K, Razia S, Ishikawa M, Ishibashi T, Yamashita H, Sato S, Sakiyama A, Yoshioka S, Kobayachi M, Nakayama S, Otsuki Y, Ishikawa N, Kyo S.
    Diseases. Feb 4;9(1):14. doi: 10.3390/diseases9010014.
  3. Detection of pure Leydig cell ovarian tumor not visible on imaging by selective venous blood sampling in a woman with secondary amenorrhea and hirsutism: A case report.
    Oride A, Kanasaki H, Okada H, Kyo S.
    Case Rep Womens Health. 2021 Feb 11;30:e00298. doi: 10.1016/j.crwh.2021.e00298.
  4. Neutropenic enterocolitis-induced sepsis and disseminated intravascular coagulation after chemotherapy: A case report.
    Yamashita H, Ishibashi T, Sato S, Sawada K, Sasamori H, Kurose S, Ishikawa N, Kyo S.
    BMC Womens Health. 2021 May 3;21(1):187. doi: 10.1186/s12905-021-01302-8.
  5. Effect of anti-Müllerian hormone on the regulation of pituitary gonadotropin subunit expression: roles of kisspeptin and its receptors in gonadotroph LβT2 cells.
    Tumurbaatar T, Kanasaki H, Tumurgan Z, Oride A, Okada H, Kyo S.
    Endocr J. 2021 May 15. doi: 10.1507/endocrj.EJ21-0085.